Fidelity Investments’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,025,300
Closed -$30.9M 2766
2016
Q2
$30.9M Sell
1,025,300
-336,105
-25% -$6.82M ﹤0.01% 1479
2016
Q1
$15M Buy
+1,361,405
New +$4.46M ﹤0.01% 1798

Fidelity Investments's CPXX Position: Q3 2016 in Review

Fidelity Investments sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 1,025,300 shares — an estimated $30.9M sold.

Fidelity Investments first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $30.9M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Fidelity Investments reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Fidelity Investments sold 1,025,300 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $30.9M.
  • Fidelity Investments first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • Fidelity Investments's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $30.9M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.